
Pharmacally
Nintedanib
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in Nintedanib
Clinical TrialsMannKind Advances Inhaled Nintedanib with Positive Phase 1b IPF DataMannKind’s Phase 1b INFLO-1 trial showed that inhaled nintedanib dry powder was well tolerated in patients with idiopathic pulmonary fibrosis, with no serious adverse events, bronchospasm, or gastrointestinal…Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.